These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22830987)

  • 1. Body mass index and the efficacy of needle-free jet injection for the administration of rapid-acting insulin analogs, a post hoc analysis.
    de Galan BE; Engwerda EE; Abbink EJ; Tack CJ
    Diabetes Obes Metab; 2013 Jan; 15(1):84-6. PubMed ID: 22830987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved pharmacokinetic and pharmacodynamic profile of rapid-acting insulin using needle-free jet injection technology.
    Engwerda EE; Abbink EJ; Tack CJ; de Galan BE
    Diabetes Care; 2011 Aug; 34(8):1804-8. PubMed ID: 21715522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the pharmacodynamic profiles of jet-injected regular human insulin versus conventionally administered insulin aspart in healthy volunteers.
    Engwerda EEC; Tack CJ; de Galan BE
    Diabetes Res Clin Pract; 2016 Nov; 121():86-90. PubMed ID: 27662042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic effects of the oral glucokinase activator AZD6370 after single doses in healthy volunteers assessed with euglycaemic clamp.
    Sjöstrand M; Ericsson H; Hartford M; Norjavaara E; Eriksson JW
    Diabetes Obes Metab; 2013 Jan; 15(1):35-41. PubMed ID: 22958202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin glulisine, a new rapid-acting insulin analogue, displays a rapid time-action profile in obese non-diabetic subjects.
    Becker RH; Frick AD; Burger F; Potgieter JH; Scholtz H
    Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):435-43. PubMed ID: 16151977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. U-100, pH-Neutral formulation of VIAject(®) : faster onset of action than insulin lispro in patients with type 1 diabetes.
    Heinemann L; Nosek L; Flacke F; Albus K; Krasner A; Pichotta P; Heise T; Steiner S
    Diabetes Obes Metab; 2012 Mar; 14(3):222-7. PubMed ID: 21981286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique.
    Cernea S; Kidron M; Wohlgelernter J; Modi P; Raz I
    Clin Ther; 2004 Dec; 26(12):2084-91. PubMed ID: 15823772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin administered by needle-free jet injection corrects marked hyperglycaemia faster in overweight or obese patients with diabetes.
    de Wit HM; Engwerda EE; Tack CJ; de Galan BE
    Diabetes Obes Metab; 2015 Nov; 17(11):1093-9. PubMed ID: 26259978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Needle-free jet injection of rapid-acting insulin improves early postprandial glucose control in patients with diabetes.
    Engwerda EE; Tack CJ; de Galan BE
    Diabetes Care; 2013 Nov; 36(11):3436-41. PubMed ID: 24089542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover study.
    Cernea S; Kidron M; Wohlgelernter J; Raz I
    Clin Ther; 2005 Oct; 27(10):1562-70. PubMed ID: 16330292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic control, reported pain and leakage with a 4 mm × 32 G pen needle in obese and non-obese adults with diabetes: a post hoc analysis.
    Hirsch LJ; Gibney MA; Li L; Bérubé J
    Curr Med Res Opin; 2012 Aug; 28(8):1305-11. PubMed ID: 22762347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarity of pharmacodynamic effects of a single injection of insulin glargine, insulin detemir and NPH insulin on glucose metabolism assessed by 24-h euglycaemic clamp studies in healthy humans.
    Sørensen LP; Brock B; Mengel A; Rungby J; Moller N; Nielsen S; Vølund A; Schmitz O
    Diabet Med; 2010 Jul; 27(7):830-7. PubMed ID: 20636965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluctuation and reproducibility of exposure and effect of insulin glargine in healthy subjects.
    Becker RH; Frick AD; Teichert L; Nosek L; Heinemann L; Heise T; Rave K
    Diabetes Obes Metab; 2008 Nov; 10(11):1105-13. PubMed ID: 18355326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects.
    Rave K; Heise T; Weyer C; Herrnberger J; Bender R; Hirschberger S; Heinemann L
    Diabet Med; 1998 Sep; 15(9):747-51. PubMed ID: 9737803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and Pharmacodynamic Variability of Insulin When Administered by Jet Injection.
    Engwerda EEC; Tack CJ; de Galan BE
    J Diabetes Sci Technol; 2017 Sep; 11(5):947-952. PubMed ID: 28303726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lispro administered by the QS-M Needle-Free Jet Injector generates an earlier insulin exposure.
    Hu J; Shi H; Zhao C; Li X; Wang Y; Cheng Q; Goswami R; Zhen Q; Mei M; Song Y; Yang S; Li Q
    Expert Opin Drug Deliv; 2016 Sep; 13(9):1203-7. PubMed ID: 27267431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin glulisine has a faster onset of action compared with insulin aspart in healthy volunteers.
    Arnolds S; Rave K; Hövelmann U; Fischer A; Sert-Langeron C; Heise T
    Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):662-4. PubMed ID: 20429049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes.
    Klein O; Lynge J; Endahl L; Damholt B; Nosek L; Heise T
    Diabetes Obes Metab; 2007 May; 9(3):290-9. PubMed ID: 17391154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin detemir under steady-state conditions: no accumulation and constant metabolic effect over time with twice daily administration in subjects with Type 1 diabetes.
    Bott S; Tusek C; Jacobsen LV; Endahl L; Draeger E; Kapitza C; Heise T
    Diabet Med; 2006 May; 23(5):522-8. PubMed ID: 16681561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rapid-acting properties of insulin aspart are preserved in elderly people with type 2 diabetes.
    Krones R; Schütte C; Heise T
    Diabetes Obes Metab; 2009 Jan; 11(1):41-4. PubMed ID: 19120432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.